全文获取类型
收费全文 | 1451篇 |
免费 | 172篇 |
国内免费 | 49篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 98篇 |
妇产科学 | 19篇 |
基础医学 | 198篇 |
口腔科学 | 44篇 |
临床医学 | 134篇 |
内科学 | 423篇 |
皮肤病学 | 30篇 |
神经病学 | 33篇 |
特种医学 | 199篇 |
外科学 | 103篇 |
综合类 | 102篇 |
预防医学 | 96篇 |
眼科学 | 9篇 |
药学 | 70篇 |
中国医学 | 3篇 |
肿瘤学 | 101篇 |
出版年
2023年 | 18篇 |
2022年 | 15篇 |
2021年 | 24篇 |
2020年 | 22篇 |
2019年 | 12篇 |
2018年 | 24篇 |
2017年 | 44篇 |
2016年 | 38篇 |
2015年 | 35篇 |
2014年 | 73篇 |
2013年 | 77篇 |
2012年 | 46篇 |
2011年 | 50篇 |
2010年 | 78篇 |
2009年 | 80篇 |
2008年 | 48篇 |
2007年 | 88篇 |
2006年 | 61篇 |
2005年 | 58篇 |
2004年 | 41篇 |
2003年 | 33篇 |
2002年 | 28篇 |
2001年 | 40篇 |
2000年 | 21篇 |
1999年 | 31篇 |
1998年 | 78篇 |
1997年 | 67篇 |
1996年 | 60篇 |
1995年 | 50篇 |
1994年 | 47篇 |
1993年 | 45篇 |
1992年 | 18篇 |
1991年 | 7篇 |
1990年 | 16篇 |
1989年 | 23篇 |
1988年 | 24篇 |
1987年 | 13篇 |
1986年 | 21篇 |
1985年 | 18篇 |
1984年 | 13篇 |
1983年 | 13篇 |
1982年 | 10篇 |
1981年 | 5篇 |
1980年 | 8篇 |
1979年 | 4篇 |
1978年 | 7篇 |
1977年 | 5篇 |
1976年 | 12篇 |
1975年 | 9篇 |
1966年 | 5篇 |
排序方式: 共有1672条查询结果,搜索用时 62 毫秒
81.
Long‐term outcomes with first‐ vs. second‐generation drug‐eluting stents in saphenous vein graft lesions 下载免费PDF全文
Nagendra R. Pokala BS Rohan V. Menon BS Siddharth M. Patel BS George Christopoulos MD Georgios E. Christakopoulos MD Anna P. Kotsia MD Bavana V. Rangan BDS MPH Michele Roesle RN Shuaib Abdullah MD Jerrold Grodin MD Dharam J. Kumbhani MD SM MRCP Jeffrey Hastings MD Subhash Banerjee MD Emmanouil S. Brilakis MD PhD 《Catheterization and cardiovascular interventions》2016,87(1):34-40
82.
Routine invasive versus selective invasive strategies for Non‐ST‐elevation acute coronary syndromes: An Updated meta‐analysis of randomized trials 下载免费PDF全文
83.
Mailliard RB Alber SM Shen H Watkins SC Kirkwood JM Herberman RB Kalinski P 《The Journal of experimental medicine》2005,202(7):941-953
In addition to their cytotoxic activities, natural killer (NK) cells can have immunoregulatory functions. We describe a distinct "helper" differentiation pathway of human CD56+CD3- NK cells into CD56+/CD83+/CCR7+/CD25+ cells that display high migratory responsiveness to lymph node (LN)-associated chemokines, high ability to produce interferon-gamma upon exposure to dendritic cell (DC)- or T helper (Th) cell-related signals, and pronounced abilities to promote interleukin (IL)-12p70 production in DCs and the development of Th1 responses. This helper pathway of NK cell differentiation, which is not associated with any enhancement of cytolytic activity, is induced by IL-18, but not other NK cell-activating factors. It is blocked by prostaglandin (PG)E2, a factor that induces a similar CD83+/CCR7+/CD25+ LN-homing phenotype in maturing DCs. The current data demonstrate independent regulation of the "helper" versus "effector" pathways of NK cell differentiation and novel mechanisms of immunoregulation by IL-18 and PGE2. 相似文献
84.
85.
Pre-B cells and other possible precursor lymphoid cell lines derived from patients with X-linked agammaglobulinemia 总被引:14,自引:6,他引:14 下载免费PDF全文
SM Fu JN Hurley JM McCune HG Kunkel RA Good 《The Journal of experimental medicine》1980,152(6):1519-1526
A group of unique Epstein-Barr virus-containing cell lines was derived from the bone marrow of three patients with X-linked agammaglobulinemia. Efforts to obtain cell lines from the peripheral blood of these patients were uniformly unsuccessful. Immunofluorescence analyses as well as biosynthetic studies with [(35)S]methionine indicated unusual patterns of Ig synthesis in many of these bone marrow derived lines. Seven of the lines were of particular interest in that two produced no Ig of any type; two others showed no Ig by fluorescence but small amounts by [(35)S]methionine labeling; one expressed only cytoplasmic μ chains without any evidence of light chain synthesis, and two produced primarily μ chains with only slight amounts of light chains. One of the lines without membrane or cytoplasmic Ig studied in detail grew like a typical lymphoid line and was carried in intermittent culture over a period of 2 yr without Ig expression. One line grew quite differently and resembled the round cell type described previously, which has been obtained from a variety of sources. The cell line with cytoplasmic μ chains and no light-chain expression had the characteristic properties of pre-B cells. Three normal type Ig-producing cell lines also were obtained from the patients. The accumulated evidence obtained in the present study indicates that these unusual cell lines represent normal precursor cells of the B-cell lineage; these grew out in these cases because of the virtual absence of mature B cells that ordinarily overgrow the culture system. However, the possibility that in certain instances they reflect abnormal Ig synthesis characteristic of the disease has not been ruled out. 相似文献
86.
Fabien Picard MD MSc Robert Avram MD MSc Guillaume Marquis‐Gravel MD MSc Victor‐Xavier Tadros MD MSc Hung Q. Ly MD SM Quentin de Hemptinne MD Jean‐François Dorval MD Philippe L. L'allier MD Jean‐François Tanguay MD 《Journal of interventional cardiology》2017,30(6):558-563
Aims
The management of patients with in‐stent restenosis (ISR) is still a major clinical challenge even in the era of drug‐eluting stents (DES). Recent studies have demonstrated acceptable clinical outcomes for the everolimus‐eluting bioresorbable vascular scaffold (BVS) ABSORB? in patients with stable coronary artery disease but data are scarce on its use in patients with ISR. We report the long‐term results of our preliminary experience with this novel approach at our institution.Methods and Results
We investigated the safety and efficacy of BVS implantation to treat ISR. 34 consecutive patients (37 lesions) underwent PCI for ISR with BVS implantation between May 2013 and June 2015 at our institution and were included in the current analysis. Follow‐up was available in 91.9% of the patients. Mean follow‐up period was 801.9 ± 179 days. One patient had definite scaffold thrombosis (ScT) 2 months after stent implantation which was treated with DES. Five patients (six lesions) experienced target lesion revascularization (TLR). The composite endpoint rate of TLR, ScT, myocardial infarction, and death occured in 6/37 lesions at follow‐up (16.2%).Conclusions
These real‐world data using BVS in patients with ISR demonstrates that ISR treatment with ABSORB? BVS is feasible but could have slightly higher target lesion failure rates as compared to DES. This proof of concept could be hypothesis‐generating for larger randomized controlled studies.87.
88.
Background
Despite extensive research, the five-year survival rate of oral squamous cell carcinoma (OSCC) patients has not improved. Effective treatment of OSCC requires the identification of molecular targets and signaling pathways to design appropriate therapeutic strategies. Several genes from the mTOR signaling pathway are known to be dysregulated in a wide spectrum of cancers. However, not much is known about the involvement of this pathway in tumorigenesis of OSCC. We therefore investigated the role of the tumor suppressor genes, TSC1 and TSC2, and other members of this pathway in tumorigenesis of OSCC. 相似文献89.
A method to smooth intensity-modulated photon beams is presented which can be applied in conjunction with any optimization algorithm. The method employs an additional soft constraint to minimize the area of the surface defined by the photon fluence. 相似文献
90.